» Articles » PMID: 27454770

Evaluation of an Automated Analysis Tool for Prostate Cancer Prediction Using Multiparametric Magnetic Resonance Imaging

Overview
Journal PLoS One
Date 2016 Jul 26
PMID 27454770
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate the diagnostic performance of an automated analysis tool for the assessment of prostate cancer based on multiparametric magnetic resonance imaging (mpMRI) of the prostate.

Methods: A fully automated analysis tool was used for a retrospective analysis of mpMRI sets (T2-weighted, T1-weighted dynamic contrast-enhanced, and diffusion-weighted sequences). The software provided a malignancy prediction value for each image pixel, defined as Malignancy Attention Index (MAI) that can be depicted as a colour map overlay on the original images. The malignancy maps were compared to histopathology derived from a combination of MRI-targeted and systematic transperineal MRI/TRUS-fusion biopsies.

Results: In total, mpMRI data of 45 patients were evaluated. With a sensitivity of 85.7% (with 95% CI of 65.4-95.0), a specificity of 87.5% (with 95% CI of 69.0-95.7) and a diagnostic accuracy of 86.7% (with 95% CI of 73.8-93.8) for detection of prostate cancer, the automated analysis results corresponded well with the reported diagnostic accuracies by human readers based on the PI-RADS system in the current literature.

Conclusion: The study revealed comparable diagnostic accuracies for the detection of prostate cancer of a user-independent MAI-based automated analysis tool and PI-RADS-scoring-based human reader analysis of mpMRI. Thus, the analysis tool could serve as a detection support system for less experienced readers. The results of the study also suggest the potential of MAI-based analysis for advanced lesion assessments, such as cancer extent and staging prediction.

Citing Articles

Computer-aided detection of prostate cancer in early stages using multi-parameter MRI: A promising approach for early diagnosis.

Tang J, Zheng X, Wang X, Mao Q, Xie L, Wang R Technol Health Care. 2024; 32(S1):125-133.

PMID: 38759043 PMC: 11191472. DOI: 10.3233/THC-248011.


PI-RADS: introducing a new human-in-the-loop AI model for prostate cancer diagnosis based on MRI.

Yu R, Jiang K, Bao J, Hou Y, Yi Y, Wu D Br J Cancer. 2023; 128(6):1019-1029.

PMID: 36599915 PMC: 10006083. DOI: 10.1038/s41416-022-02137-2.


Computer-aided diagnosis in prostate cancer: a retrospective evaluation of the Watson Elementary system for preoperative tumor characterization in patients treated with robot-assisted radical prostatectomy.

Vittori G, Bacchiani M, Grosso A, Raspollini M, Giovannozzi N, Righi L World J Urol. 2023; 41(2):435-441.

PMID: 36595077 DOI: 10.1007/s00345-022-04275-x.


Prostate Cancer Detection with mpMRI According to PI-RADS v2 Compared with Systematic MRI/TRUS-Fusion Biopsy: A Prospective Study.

Sauck A, Keller I, Hainc N, Pfofe D, Najafi A, John H Tomography. 2022; 8(4):2020-2029.

PMID: 36006067 PMC: 9416664. DOI: 10.3390/tomography8040169.


Diagnostic accuracy of different computer-aided diagnostic systems for prostate cancer based on magnetic resonance imaging: A systematic review with diagnostic meta-analysis.

Xing X, Zhao X, Wei H, Li Y Medicine (Baltimore). 2021; 100(3):e23817.

PMID: 33545946 PMC: 7837946. DOI: 10.1097/MD.0000000000023817.


References
1.
Vos P, Hambrock T, Barenstz J, Huisman H . Computer-assisted analysis of peripheral zone prostate lesions using T2-weighted and dynamic contrast enhanced T1-weighted MRI. Phys Med Biol. 2010; 55(6):1719-34. DOI: 10.1088/0031-9155/55/6/012. View

2.
Thompson J, Moses D, Shnier R, Brenner P, Delprado W, Ponsky L . Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study. J Urol. 2014; 192(1):67-74. DOI: 10.1016/j.juro.2014.01.014. View

3.
Schimmoller L, Quentin M, Arsov C, Lanzman R, Hiester A, Rabenalt R . Inter-reader agreement of the ESUR score for prostate MRI using in-bore MRI-guided biopsies as the reference standard. Eur Radiol. 2013; 23(11):3185-90. DOI: 10.1007/s00330-013-2922-y. View

4.
Barentsz J, Richenberg J, Clements R, Choyke P, Verma S, Villeirs G . ESUR prostate MR guidelines 2012. Eur Radiol. 2012; 22(4):746-57. PMC: 3297750. DOI: 10.1007/s00330-011-2377-y. View

5.
Iczkowski K, Casella G, Seppala R, Jones G, Mishler B, Qian J . Needle core length in sextant biopsy influences prostate cancer detection rate. Urology. 2002; 59(5):698-703. DOI: 10.1016/s0090-4295(02)01515-7. View